Literature DB >> 11973166

Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery.

Solomon Aronson1, Denis Boisvert, William Lapp.   

Abstract

UNLABELLED: Isolated systolic blood pressure has not been sufficiently studied in the perioperative setting and may contribute to morbidity and mortality after coronary artery bypass grafting (CABG) surgery. Our objective was to determine the prevalence of isolated systolic hypertension among patients who had CABG surgery and to assess whether isolated systolic hypertension is associated with perioperative and postoperative in-hospital morbidity or mortality. Patients who underwent CABG were selected from a prospective epidemiological study involving 2417 patients in 24 medical centers. Patients were classified as having normal preoperative blood pressure, isolated systolic hypertension (systolic blood pressure >140 mm Hg), diastolic hypertension (diastolic blood pressure >90 mm Hg), or a combination of these. Demographic risk factors (age, sex, and ethnicity), clinical risk factors (diabetes mellitus, increased cholesterol, antihypertensive medications, history of congestive heart failure, myocardial infarction, hypertension, and neurological deficits), and behavioral risk factors (smoking and heavy drinking) were controlled for statistically. Adverse outcomes included left ventricular dysfunction, cerebral vascular dysfunction or events, renal insufficiency or failure, and all-cause mortality. Isolated systolic hypertension was found in 29.6% of patients. Unadjusted isolated systolic hypertension was associated with a 40% increased risk of adverse outcomes (odds ratio, 1.4; confidence interval, 1.1-1.7). After adjusting for other potential risk factors, the increased risk of adverse outcomes with isolated systolic hypertension was 30%. We conclude that isolated systolic hypertension is associated with a 40% increase in the likelihood of cardiovascular morbidity perioperatively in CABG patients. This increase remains present regardless of antihypertensive medications, anesthetic techniques, and other perioperative cardiovascular risk factors (e.g., age older than 60 yr or history of congestive heart failure, myocardial infarction, or diabetes). IMPLICATIONS: Isolated systolic hypertension is associated with a 40% increase in the likelihood of perioperative cardiovascular morbidity in coronary artery surgery patients.

Entities:  

Mesh:

Year:  2002        PMID: 11973166     DOI: 10.1097/00000539-200205000-00005

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  28 in total

Review 1.  Drugs for the perioperative control of hypertension: current issues and future directions.

Authors:  Robert Feneck
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Perioperative hypertensive emergencies.

Authors:  Solomon Aronson
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

3.  General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent.

Authors:  Sangeeta Das; Kirsty Forrest; Simon Howell
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

4.  Differences in ward-to-cath lab systolic blood pressure predicts long-term adverse outcomes after drug-eluting stent implantation.

Authors:  Ae-Young Her; Soe Hee Ann; Jun Ho Lee; Jong Min Kim; Yong Hoon Kim; Scot Garg; Gillian Balbir Singh; Eun-Seok Shin
Journal:  Heart Vessels       Date:  2014-07-26       Impact factor: 2.037

5.  Management of hypertension in patients undergoing surgery.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-05

Review 6.  Novel biomarkers for cardiac surgery-associated acute kidney injury: a skeptical assessment of their role.

Authors:  David Sidebotham
Journal:  J Extra Corpor Technol       Date:  2012-12

Review 7.  Perioperative control of hypertension: when will it adversely affect perioperative outcome?

Authors:  John W Sear
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 8.  Left ventricular diastolic dysfunction of the cardiac surgery patient; a point of view for the cardiac surgeon and cardio-anesthesiologist.

Authors:  Efstratios E Apostolakis; Nikolaos G Baikoussis; Haralabos Parissis; Stavros N Siminelakis; Georgios S Papadopoulos
Journal:  J Cardiothorac Surg       Date:  2009-11-24       Impact factor: 1.637

9.  Treatment of perioperative hypertension: Is clevidipine the answer?

Authors:  Joseph D Tobias
Journal:  Saudi J Anaesth       Date:  2009-07

10.  Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?

Authors:  Ashraf Fayad; Homer Yang
Journal:  Curr Cardiol Rev       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.